
Avidity Biosciences Inc (RNA) is ready for next Episode as it posted an annual sales of 10,900 K
On Tuesday, Avidity Biosciences Inc (NASDAQ: RNA) was 2.47% up from the session before settling in for the closing price of $29.15. A 52-week range
On Tuesday, Avidity Biosciences Inc (NASDAQ: RNA) was 2.47% up from the session before settling in for the closing price of $29.15. A 52-week range
Avidity Biosciences Inc (NASDAQ: RNA) kicked off on Monday, down -5.00% from the previous trading day, before settling in for the closing price of $31.37.
As on Thursday, Avidity Biosciences Inc (NASDAQ: RNA) got off with the flyer as it spiked 4.00% to $35.59, before settling in for the price
Avidity Biosciences Inc (NASDAQ: RNA) on Monday, soared 7.07% from the previous trading day, before settling in for the closing price of $30.98. Within the
A new trading day began on Friday, with Avidity Biosciences Inc (NASDAQ: RNA) stock price down -0.75% from the previous day of trading, before settling
Avidity Biosciences Inc (NASDAQ: RNA) on Friday, soared 4.76% from the previous trading day, before settling in for the closing price of $28.97. Within the
A new trading day began on Monday, with Avidity Biosciences Inc (NASDAQ: RNA) stock price up 8.50% from the previous day of trading, before settling
Avidity Biosciences, Inc. (NASDAQ: RNA) demonstrated a bullish trajectory on the United States market graphs yesterday, experiencing a remarkable uptick of 19.92% to culminate the
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.